Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VRML

Vermillion (VRML) Stock Price, News & Analysis

Vermillion logo

About Vermillion Stock (NASDAQ:VRML)

Advanced Chart

Key Stats

Today's Range
$0.08
$0.09
50-Day Range
$2.54
$4.24
52-Week Range
$0.35
$5.78
Volume
104,956 shs
Average Volume
440,144 shs
Market Capitalization
$7.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.

Receive VRML Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vermillion and its competitors with MarketBeat's FREE daily newsletter.

VRML Stock News Headlines

Camellia Vermillion
Dr. Richard L. Knutson
Elon’s 2025 Silver Crisis (What It Means for You)
Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.
Vermillion Elementary School
Dr. Kenneth J. Vermillion
Vermillion High School
Sanford Vermillion Medical Center
See More Headlines

VRML Stock Analysis - Frequently Asked Questions

Vermillion, Inc. (NASDAQ:VRML) announced its earnings results on Thursday, August, 8th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm had revenue of $1.14 million for the quarter. Vermillion had a negative trailing twelve-month return on equity of 155.25% and a negative net margin of 307.31%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vermillion investors own include CombiMatrix (CBMX), Accelerate Diagnostics (AXDX), Himax Technologies (HIMX), Charter Communications (CHTR), Idera Pharmaceuticals (IDRA), Magnachip Semiconductor (MX) and Cardiff Oncology (TROV).

Company Calendar

Last Earnings
8/08/2019
Today
5/28/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:VRML
Fax
N/A
Employees
43
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.24 million
Net Margins
-307.31%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.54 million
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
0.97

Miscellaneous

Free Float
N/A
Market Cap
$8.46 million
Optionable
Not Optionable
Beta
3.47
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:VRML) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners